“When information is not enough”: A model for understanding BRCA -positive previvors’ information needs regarding hereditary breast and ovarian cancer risk-Reference-Cited by-同舟云学术

“When information is not enough”: A model for understanding BRCA -positive previvors’ information needs regarding hereditary breast and ovarian cancer risk

Published:2017-09 Issue:9 Volume:100 Page:1738-1743
ISSN:0738-3991
Container-title:Patient Education and Counseling
language:en
Short-container-title:Patient Education and Counseling

Author:

Dean Marleah,Scherr Courtney L.,Clements Meredith,Koruo Rachel,Martinez Jennifer,Ross Amy

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE;Mavaddat;J. Natl. Cancer Inst.,2013

2. Physicians’ communicative strategies in interacting with internet-informed patients: results from a qualitative study;Caiata-Zufferey;Health Commun.,2012

3. Decision making after BRCA genetic testing;Connors;Clin. J. Oncol. Nurs.,2014

4. Confronting Hereditary Breast and Ovarian Cancer: Identify Your Risk, Understand Your Options, Change Your Destiny;Friedman,2012

5. Risk management options elected by women after testing positive for a BRCA mutation;Garcia;Gynecol. Oncol.,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Information needs of women with BRCA mutations regarding cancer risk management and decision-making;European Journal of Oncology Nursing;2024-10

2. Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome;Breast Cancer Research and Treatment;2024-07-24

3. Predictors of knowledge and knowledge gain after decision aid use among women with BRCA1/2 pathogenic variants;Patient Education and Counseling;2024-07

4. Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner;Seminars in Oncology Nursing;2024-06

5. Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial;Public Health Genomics;2024